静脉-动脉体外膜氧合救治羊水栓塞
本研究纳入2008年8月至2021年2月两家高ECMO容量中心收治的、经VA-ECMO救治并符合诊断标准的10例羊水栓塞(AFE)产妇,年龄中位数33岁(范围24-40),SAPS II 69(56-81),妊娠36周(30-41)。ECMO前7例发生心脏骤停、2例在心肺复苏下置管,血流动力学严重受损:正性肌力药评分370(55-1530)μg/kg/min、左心室射血分数14(0-40)%、乳酸12(2-30)mmol/L。尽管ECMO前病情极重并大量输血,出院存活率为70%;中位随访44个月后健康相关生活质量低于年龄匹配对照,角色-生理、躯体疼痛和总体健康维度仍严重受损。作者结论支持在严重DIC和持续出血情况下使用VA-ECMO,并提出未来研究应关注个体化、以患者为中心的康复方案以改善该人群健康相关生活质量。
要点
- 两中心13年间共10例符合诊断标准的AFE产妇接受VA-ECMO,出院存活率70%。
- ECMO前病情极重:7例心脏骤停、2例心肺复苏下置管,左心室射血分数14(0-40)%、乳酸12(2-30)mmol/L。
- 作者结论支持在严重DIC和持续出血情况下使用VA-ECMO救治AFE。
- 中位随访44个月,存活者健康相关生活质量低于年龄匹配对照,角色-生理、躯体疼痛、总体健康维度仍严重受损。
- 作者建议未来研究聚焦个体化、以患者为中心的康复方案以改善该人群健康相关生活质量。
适用人群与场景
- 2008年8月至2021年2月两家高ECMO容量中心收治的、经VA-ECMO救治并符合作者诊断标准的羊水栓塞产妇,共10例,年龄中位数33岁(范围24-40),SAPS II 69(56-81),妊娠36周(30-41)。
诊断标准与关键阈值
- 符合作者诊断标准的羊水栓塞患者纳入;具体诊断标准条目原文未列出。
处置流程与药物剂量
- 对符合诊断标准的AFE产妇启动VA-ECMO;10例中7例在ECMO前发生心脏骤停,2例在心肺复苏下置管。
红旗征与不能漏的情况
- ECMO前7例发生心脏骤停、2例需在心肺复苏下置管。
- ECMO前血流动力学严重受损:正性肌力药评分370(55-1530)μg/kg/min、左心室射血分数14(0-40)%、乳酸12(2-30)mmol/L。
- AFE合并严重DIC和持续出血。
研究设计与关键结果
- 研究类型为两中心病例系列,纳入2008年8月至2021年2月共10例经VA-ECMO救治的AFE产妇。
- 出院存活率70%,尽管ECMO前病情极重并大量输注血制品。
- 中位随访44个月,存活者健康相关生活质量低于年龄匹配对照,角色-生理、躯体疼痛和总体健康维度仍严重受损。
证据类型、等级与局限
- 证据类型:两中心病例系列(10例)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在羊水栓塞这一罕见围分娩期并发症中,其结果支持在严重DIC和持续出血情况下使用VA-ECMO。
- 作者建议未来研究应聚焦个体化、以患者为中心的康复方案,以改善该人群的健康相关生活质量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Amniotic fluid embolism (AFE) is a rare but often catastrophic complication of pregnancy that leads to cardiopulmonary dysfunction and severe disseminated intravascular coagulopathy (DIC). Although few case reports have reported successful use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) with AFE, concerns can be raised about the increased bleeding risks with that device.
METHODS: This study included patients with AFE rescued by VA-ECMO hospitalized in two high ECMO volume centers between August 2008 and February 2021. Clinical characteristics, critical care management, in-intensive care unit (ICU) complications, and hospital outcomes were collected. ICU survivors were assessed for health-related quality of life (HRQL) in May 2021.
RESULTS: During that 13-year study period, VA-ECMO was initiated in 54 parturient women in two high ECMO volume centers. Among that population, 10 patients with AFE [median (range) age 33 (24-40), SAPS II at 69 (56-81)] who fulfilled our diagnosis criteria were treated with VA-ECMO. Pregnancy evolved for 36 (30-41) weeks. Seven patients had a cardiac arrest before ECMO and two were cannulated under cardiopulmonary resuscitation. Pre-ECMO hemodynamic was severely impaired with an inotrope score at 370 (55-1530) μg/kg/min, a severe left ventricular ejection fraction measured at 14 (0-40)%, and lactate at 12 (2-30) mmol/L. 70% of these patients were alive at hospital discharge despite an extreme pre-ECMO severity and massive blood product transfusion. However, HRQL was lower than age-matched controls and still profoundly impaired in the role-physical, bodily pain, and general health components after a median of 44 months follow-up.
CONCLUSION: In this rare per-delivery complication, our results support the use of VA-ECMO despite intense DIC and ongoing bleeding. Future studies should focus on customized, patient-centered, rehabilitation programs that could lead to improved HRQL in this population.
参考来源
- Aissi James S, Klein T, Lebreton G, et al. Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation. Crit Care. 2022. PMID: 35392980. doi:10.1186/s13054-022-03969-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。